Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs
Accomplished biotech and CRO leader brings 25+ years of global oncology drug development and operational
{fullname}
About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts
Related posts
---
Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement
SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research
---
George Clinical Rebrands as Emerald Clinical Trials
New name reflects company's growth and vision to help bring certainty and transparency to global clinical
---
CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth
Dr. Jean-Luc Herbeaux appointed Chief Executive Officer of CordenPharma, effective 1 October 2026 Dr.
---
Accely Appoints Michael Lim as Director, Strategy & Growth for Singapore and Southeast Asia
SINGAPORE, Sept. 8, 2026 /PRNewswire/ -- Accely, a global SAP Gold Partner and autonomous enterprise
